--
+$0.000000(+11.20%)
Market Cap
--
24h High
$0.111885
24h Low
$0.092988
24h Turnover
$55.86M
Total Supply
10.00B
Market Sentiment
Neutral
0 Extreme Fear100 Extreme Greed
- Yesterday
- 50
- Normal
- Last Week
- 30
- Fear
- Last Month
- 71
- Greed
The Fear & Greed Index is currently 28/100, in the Fear zone; change from yesterday: -22, from last week: -2, and from last month: -43. Lower values indicate more fearful sentiment, while higher values indicate more greedy sentiment. This does not represent price change.
About Cap (CAP)
Cap is a credit platform backed by financial guarantees. The platform relies on a market of underwriters to independently originate and insure USD loans out of its portfolio to companies in the real economy. In return, underwriters receive a premium from the credit spreads of loans. Dollar depositors then earn a secured yield that’s insured by underwriters.
How to Buy and Use Cap (CAP)
More CAP Articles
Cap (CAP) Basics & Market Insights
Market Analysis
Apple Regains Its Position as the World’s Largest Company by Market Cap: Why Is AAPL Holding Up Amid the Tech Stock Sell-Off?On November 6, 2026, Apple’s market cap once again climbed above $5 trillion and took the No. 1 spot globally. This article breaks down three layers of mechanisms that helped it hold up amid a selloff in tech stocks: differences in the pace of AI capital expenditures, cash flow and buybacks that provide support, and a shift in market style from “narrative premium” to “earni2026-11-06
What Is the Gate Card Cashback Rate? Six Tiers and Points Limits ExplainedGate Card cashback is issued in the form of points. The rate varies by card tier, ranging from 1% to 8%. We explain the monthly points cap, per-transaction limit, and redemption rules for each tier in one place.2026-11-06
Moderna (MRNA) Q3 Earnings Preview: Shares Rally 13% — Can Two Key R&D Developments Support Its Valuation?Moderna shares rose 13.11% before its earnings report, reaching $258.38. Its market cap returned to $103.155 billion. An Ebola vaccine received WHO approval to enter Phase II/III, and early data on a multiple myeloma therapy were selected for an oral presentation at ASH. This article breaks down the quality of data for two candidate drugs, their financial fundamentals, and the veri2026-11-05
Risk Disclosure
Cryptocurrencies are high-risk assets and are subject to significant price volatility. The value of digital assets may fluctuate sharply within a short period of time, and you may lose part or all of your investment principal. Past performance does not guarantee future results.
Before engaging in any transaction, you should carefully assess your financial situation, investment experience, investment objectives, and risk tolerance, and ensure that you fully understand the characteristics and risks associated with cryptocurrencies. If necessary, you are advised to consult an independent professional advisor with the appropriate qualifications.
Disclaimer
The information provided on this page is for general reference only and does not constitute any form of investment, financial, legal, tax, or trading advice, nor does it constitute any offer, solicitation, or recommendation.
Gate makes no representations or warranties regarding the accuracy, completeness, or timeliness of the relevant information and assumes no liability for any losses arising from users' own decisions based on such information.
Gate products and services may be restricted in certain jurisdictions or for certain users. Before using the relevant services, please ensure compliance with applicable laws and regulations, and refer to the User Agreement for provisions regarding restricted regions and service limitations.